← Leaderboards
Yingze Zhang
University Of Pittsburgh At Pittsburgh
$590,480
Attributed
$802,230
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $231K · FY2015–20$250K$187.5K$125K$62.5K$0
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$802,230 · 2
By mechanism
R21$802,230 · 2
Top collaborators
- Frank C. Sciurba2 shared
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Kirk P Conra$10,657,362
- Carol A Feghali-Bostwick$17,984,586
- James H-C. Wang$6,970,587
- Kathryn S. Torok$2,024,095
- Anna E Lokshin$15,272,209
Others in their field
Top investigators on “Base”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$613,567,095
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$521,411,998
- Leonard Freedman · Leidos Biomedical Research, Inc.$515,995,429
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$507,042,060
Research focus
BaseLungImpairmentEventPre-ClinicalProteinsBiological MarkersBindingAntibodiesCause Of DeathCellsCharacteristicsChildhoodChromatin ImmunoprecipitationCohort StudiesCase ControlCohortClinical TrialsBlood ProteinsCpg IslandsDatabasesData MiningData ReportingClinical Management
Grant awards (4)
A novel approach to reverse the ineffectiveness of relaxin-based anti-fibrotic therapy in SSc$172,150
R21 · FY2020 · AR · contact PI
A novel approach to reverse the ineffectiveness of relaxin-based anti-fibrotic therapy in SSc$206,580
R21 · FY2019 · AR · contact PI
Biomarkers predictive of Lung Function Decline in physiologically Normal Smokers$231,000
R21 · FY2016 · HL
Biomarkers predictive of Lung Function Decline in physiologically Normal Smokers$192,500
R21 · FY2015 · HL